Nyxoah (NYXH) Debt to Equity (2020 - 2025)

Nyxoah's quarterly Debt to Equity came in at $0.83 in Q4 2025, up 394.02% year-on-year from $0.17 in Q4 2024, and up 394.02% quarter-over-quarter from $0.17 in Q4 2024.

Nyxoah has reported Debt to Equity for 6 years, with the latest figure at $0.83 in Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity rose 394.02% year-over-year to $0.83; the trailing twelve-month figure through Dec 2025 stood at $0.83 (up 394.02% YoY), and the FY2025 full-year result was $0.83, up 394.02% from the prior year.
  • Debt to Equity for Q4 2025 stood at $0.83, up from $0.17 in the prior quarter.
  • The five-year high for Debt to Equity was $1.93 in Q4 2022, with the low at -$0.05 in Q4 2023.
  • Average Debt to Equity over 5 years is $0.95, with a median of $0.83 recorded in 2025.
  • Year-over-year, Debt to Equity plunged 102.81% in 2023 and soared 408.38% in 2024.
  • Tracing NYXH's Debt to Equity over 5 years: stood at $1.89 in 2021, then rose by 2.34% to $1.93 in 2022, then plunged by 102.81% to -$0.05 in 2023, then jumped by 408.38% to $0.17 in 2024, then soared by 394.02% to $0.83 in 2025.
  • The last three Debt to Equity figures came in at $0.83 (Q4 2025), $0.17 (Q4 2024), and -$0.05 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.72
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.04
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.07
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 1.02
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.30
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 1.57
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.45
10 Nyxoah 1,248.49 1,248.49 4.26 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.83
Dec 31, 2024 0.17
Dec 31, 2023 -0.05
Dec 31, 2022 1.93
Dec 31, 2021 1.89
Dec 31, 2020 2.17